Hypermethylation of the HIC1 promoter and aberrant expression of HIC/SIRT1 may be useful for assessing the risk of developing thyroid papillary carcinoma and may be a novel therapeutic target. Here, SIRT1 is linked to thyroid gland papillary carcinoma.